Evidence mapPaperPMID 41301487Full record

ArticleBiomolecules2025

Heteroaromatic Hybrid Benzimidazole/Oxadiazole (BZ/OZ) Ligand and Its Sm(III) Complex: Study of Their Antibacterial Activity, Toxicological Prediction and Interaction with Different Model Membranes.

Alberto Aragón-Muriel, Alessio Ausili, Luciana Sampaio Lima, Cleydson B R Santos, David Morales-Morales, Dorian Polo-Cerón

Abstract read
In one paragraph

Article in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alberto Aragón-MurielGrupo de Investigaciones Bioquímicas (GIB), Departamento de Química, Universidad del Magdalena, Santa Marta 470004, Colombia.ORCID 0000-0001-5554-9592
Alessio AusiliDepartamento de Bioquímica y Biología Molecular (A), Facultad de Veterinaria, International Campus of Excellence Mare Nostrum, Universidad de Murcia, Apartado. 4021, E-30100 Murcia, Spain.ORCID 0000-0001-5270-6337
Luciana Sampaio LimaLaboratório de Modelagem e Química Computacional, Universidade Federal do Amapá, Macapá 68903-419, Amapá, Brazil.ORCID 0000-0003-0933-4296
Cleydson B R SantosLaboratório de Modelagem e Química Computacional, Universidade Federal do Amapá, Macapá 68903-419, Amapá, Brazil.ORCID 0000-0002-0271-335X
David Morales-MoralesInstituto de Química, Universidad Nacional Autónoma de México, Circuito Exterior S/N, Ciudad Universitaria, Alcaldía Coyoacán, Ciudad de México C.P. 04510, Mexico.ORCID 0000-0002-7984-1819
Dorian Polo-CerónLaboratorio de Investigación en Catálisis y Procesos (LICAP-Bioinorgánica), Departamento de Química, Facultad de Ciencias Naturales y Exactas, Universidad del Valle, Calle 13 No. 100-00, Santiago de Cali 76001, Colombia.ORCID 0000-0002-6778-2209

Funding

University of Magdalena VIN2024203
6 · The paper itself

Abstract

Two heteroaromatic hybrid compounds were synthesized and characterized using various analytical techniques. The results indicate that the benzimidazole/oxadiazole (BZ/OZ) metal derivative exhibits a tridentate coordination mode, where the carbonyl, imidazole and oxadiazole groups participate in coordination with the metal, in a ratio of 2:1 of the ligand to the metal. The antibacterial activities of the organic ligand and its metal complex were determined by in vitro tests against both Gram-positive bacterial strains and Gram-negative bacterial strains using the broth microdilution method. The metal complex showed greater antibacterial activities compared to the precursor ligand against all evaluated microorganisms. The results obtained through in silico predictions revealed significant toxicological differences among the analyzed molecules, suggesting special attention in the use of the ligand due to its possible carcinogenicity in mice and a need for structural modifications in the complex to reduce its carcinogenicity and toxicity. Furthermore, a biophysical study of the interaction of the BZ/OZ derivatives with different model membranes was explored through differential scanning calorimetry (DSC), simultaneous small- and wide-angle X-ray diffraction (SAXD and WAXD) and infrared spectroscopy (FT-IR). The results indicate that the compounds influenced membrane properties without significantly altering the lamellar organization. The findings suggest potential applications in understanding lipid interactions, elucidating toxicology and developing antibacterial agents.

Indexed as

Anti-Bacterial AgentsBenzimidazolesCoordination ComplexesOxadiazolesAnimalsGram-Negative BacteriaGram-Positive BacteriaLigandsMembranes, ArtificialMicrobial Sensitivity TestsAnti-Bacterial AgentsbenzimidazoleBenzimidazolesCoordination ComplexesLigandsMembranes, ArtificialOxadiazolesantibacterial activitybiophysical studycoordination complexheteroaromatic hybridmodel membranestoxicological prediction

Identifiers

PMID41301487
PMCPMC12650029

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.